“Efficiency Integrated Chemotherapy With EGFR Receptor Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer and an Activating EGFR Gene Mutation”. Voprosy Onkologii, vol. 67, no. 2, May 2022, pp. 246-53, https://doi.org/10.37469/0507-3758-2021-67-2-246-253.